Bibliografia Sunday, M. E., Hua, J., Reyes, B., Masui, H. and Torday, J. S., 1993. Anti-bombesin monoclonal antibodies modulate f<strong>eta</strong>l mouse lung growth and maturation in utero and in organ cultures. Anat Rec. 236, 25-32; discussion 33-24. Sunday, M. E., Hua, J., Torday, J. S., Reyes, B. and Shipp, M. A., 1992. CD10/neutral endopeptidase 24.11 in developing human f<strong>eta</strong>l lung. Patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest. 90, 2517-2525. Svoboda, K. S. and Currie, B. L., 1992. Evaluation of some substrates and potential inhibitors of tissue pyroglutamyl aminopeptidase I. Neuropeptides. 21, 85-92. Szabolcs, I., Schultheiss, H., Astier, H. and Horster, F. A., 1991. Age-related decreases in the thyrotropin (TSH) responsiveness to thyrotropin-releasing-hormone (TRH) stimulation and to the inhibitory effect of triiodothyronine (T3); in vitro study on superfused rat pituitaries. Exp Gerontol. 26, 347-355. Szappanos, A. E., Lakics, V. and Erdo, S. L., 1994. Pronounced increase in prolyl endopeptidase activity in primary cultures of rat cerebral cortex during neuronal differentiation. Neurobiology (Bp). 2, 211-221. Szeltner, Z., Rea, D., Renner, V., Juliano, L., Fulop, V. and Polgar, L., 2003. Electrostatic environment at the active site of prolyl oligopeptidase is highly influential during substrate binding. J Biol Chem. 278, 48786-48793. Szewczuk, A. and Mulczyk, M., 1969. Pyrrolidonyl peptidase in bacteria. The enzyme from Bacillus subtilis. Eur J Biochem. 8, 63-67. Takahashi, A., Aoshiba, K. and Nagai, A., 2002. Apoptosis of wound fibroblasts induced by oxidative stress. Exp Lung Res. 28, 275-284. Takahashi, S., Kato, H., Seki, T., Noguchi, T., Naito, H., Aoyagi, T. and Umezawa, H., 1985. Bestatin, a microbial aminopeptidase inhibitor, inhibits DNA synthesis induced by insulin or epidermal growth factor in primary cultured rat hepatocytes. J Antibiot (Tokyo). 38, 1767-1773. Takahashi, S., Ohishi, Y., Kato, H., Noguchi, T., Naito, H. and Aoyagi, T., 1989. The effects of bestatin, a microbial aminopeptidase inhibitor, on epidermal growth factor-induced DNA synthesis and cell division in primary cultured hepatocytes of rats. Exp Cell Res. 183, 399-412. Tanaka, H., Chinami, M., Mizushima, T., Ogasahara, K., Ota, M., Tsukihara, T. and Yutani, K., 2001. X-ray crystalline structures of pyrrolidone carboxyl peptidase from a hyperthermophile, Pyrococcus furiosus, and its cys-free mutant. J Biochem (Tokyo). 130, 107-118. Tangalakis, K., Lumbers, E. R., Moritz, K. M., Towstoless, M. K. and Wintour, E. M., 1992. Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp Physiol. 77, 709-717. Tank, J. E., Vora, J. P., Houghton, D. C. and Anderson, S., 1994. Altered renal vascular responses in the aging rat kidney. Am J Physiol. 266, F942-948. Tate, S. S., 1981. Purification and properties of a bovine brain thyrotropin-releasingfactor deamidase. A post-proline cleaving enzyme of limited specificity. Eur J Biochem. 118, 17-23. Taylor, T., Gyves, P. and Burgunder, J. M., 1990. Thyroid hormone regulation of TRH mRNA levels in rat paraventricular nucleus of the hypothalamus changes during ontogeny. Neuroendocrinology. 52, 262-267. Taylor, W. L. and Dixon, J. E., 1978. Characterization of a pyroglutamate aminopeptidase from rat serum that degrades thyrotropin-releasing hormone. J Biol Chem. 253, 6934-6940. Bibliografia 245
Bibliografia ten Have-Opbroek, A. A., 1986. The structural composition of the pulmonary acinus in the mouse. A scanning electron microscopical and developmental-biological analysis. Anat Embryol (Berl). 174, 49-57. Terenius, L., 1973. Characteristics of the "receptor" for narcotic analgesics in synaptic plasma membrane fraction from rat brain. Acta Pharmacol Toxicol (Copenh). 33, 377-384. Terwel, D., Bothmer, J., Wolf, E., Meng, F. and Jolles, J., 1998. Affected enzyme activities in Alzheimer's disease are sensitive to antemortem hypoxia. J Neurol Sci. 161, 47-56. Thompson, M. M., Oyama, T. T., Kelly, F. J., Kennefick, T. M. and Anderson, S., 2000. Activity and responsiveness of the renin-angiotensin system in the aging rat. Am J Physiol Regul Integr Comp Physiol. 279, R1787-1794. Thorn, N. A., Russell, J. T., Torp-Pedersen, C. and Treiman, M., 1978. Calcium and neurosecretion. Ann N Y Acad Sci. 307, 618-639. Timiras, P. S., 1994. Disuse and aging: same problem, different outcomes. J Gravit Physiol. 1, P5-7. Toide, K., Fujiwara, T., Iwamoto, Y., Shinoda, M., Okamiya, K. and Kato, T., 1996. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide m<strong>eta</strong>bolism in the rat brain. Naunyn Schmiedebergs Arch Pharmacol. 353, 355- 362. Toide, K., Okamiya, K., Iwamoto, Y. and Kato, T., 1995. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on prolyl endopeptidase activity and substance P- and arginine-vasopressin-like immunoreactivity in the brains of aged rats. J Neurochem. 65, 234-240. Toide, K., Shinoda, M., Fujiwara, T. and Iwamoto, Y., 1997a. Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on spatial memory and central cholinergic neurons in aged rats. Pharmacol Biochem Behav. 56, 427-434. Toide, K., Shinoda, M., Iwamoto, Y., Fujiwara, T., Okamiya, K. and Uemura, A., 1997b. A novel prolyl endopeptidase inhibitor, JTP-4819, with potential for treating Alzheimer's disease. Behav Brain Res. 83, 147-151. Toide, K., Shinoda, M. and Miyazaki, A., 1998. A novel prolyl endopeptidase inhibitor, JTP-4819--its behavioral and neurochemical properties for the treatment of Alzheimer's disease. Rev Neurosci. 9, 17-29. Toth-Heyn, P. and Guignard, J. P., 2002. Bradykinin in the newborn kidney. Nephron. 91, 571-575. Tsang, D., Ho, K. P. and Wen, H. L., 1986. Ontogenesis of multiple forms of monoamine oxidase in rat brain regions and liver. Dev Neurosci. 8, 243-250. Tsukahara, T., Ishiura, S. and Sugita, H., 1990. Regulation of prolyl endopeptidase activity by the intracellular redox state. J Biol Chem. 265, 21448-21453. Tsuru, D., Fujiwara, K. and Kado, K., 1978. Purification and characterization of Lpyrrolidonecarboxylate peptidase from Bacillus amyloiliquefaciens. J Biochem (Tokyo). 84, 467-476. Tsuru, D., Sakabe, K., Yoshimoto, T. and Fujiwara, K., 1982. Pyroglutamyl peptidase from chicken liver: purification and some properties. J Pharmacobiodyn. 5, 859-868. Tsuruo, Y., Hokfelt, T. and Visser, T., 1987. Thyrotropin releasing hormone (TRH)immunoreactive cell groups in the rat central nervous system. Exp Brain Res. 68, 213-217. 246 Bibliografia
- Page 1 and 2:
Jakintza-arloa: Medikuntza Prolil e
- Page 3 and 4:
UNIVERSIDAD DEL PAIS VASCO Eman ta
- Page 5 and 6:
Doktore-tesia Naiara Agirregoitia M
- Page 7 and 8:
Esker onak Lan hau hasi nuenetik mo
- Page 9:
David Artola Blancoren Oroimenez Es
- Page 12 and 13:
Aurkibidea SARRERA 1.NEUROPEPTIDOAK
- Page 14 and 15:
Aurkibidea 7.4. BIRIKAK 65 7.5. GIL
- Page 16:
Aurkibidea 2.4.PIROGLUTAMIL PEPTIDA
- Page 19 and 20:
Sarrera 2 Sarrera
- Page 21 and 22:
Neuropeptidoak dira: 4 Hurrengo tau
- Page 23 and 24:
Neuropeptidoak 6 1.2.4. Askapena Ne
- Page 26 and 27:
Tirotropinaren Hormona Askatzailea
- Page 28 and 29:
Tirotropinaren Hormona Askatzailea
- Page 30 and 31:
Tirotropinaren Hormona Askatzailea
- Page 32 and 33:
Tirotropinaren Hormona Askatzailea
- Page 34:
Tirotropinaren Hormona Askatzailea
- Page 37 and 38:
Prolil endopeptidasa burututako leh
- Page 39 and 40:
Prolil endopeptidasa 22 3.3. PROLIL
- Page 41 and 42:
Prolil endopeptidasa 24 3.5. GARRAN
- Page 43 and 44:
Piroglutamil peptidasa I Mutagenesi
- Page 45 and 46:
Piroglutamil peptidasa I Katuaren g
- Page 48 and 49:
5. GARUN GARAPENA 5.1. SARRERA 5.1.
- Page 50 and 51:
Garun garapena Rhombentzefaloaren k
- Page 52 and 53:
Garun garapena mekanismoa hurrengoe
- Page 54 and 55:
Garun garapena Oinarrizko morfologi
- Page 56 and 57:
Garun garapena egunetan, baina 40.
- Page 58 and 59:
Garun garapena badaude, eta entzima
- Page 60 and 61:
Garun garapena neuronen genesia (Fr
- Page 62 and 63:
Garun garapena hipotiroideoaren adi
- Page 64 and 65:
Garun garapena azpiko zati bat. Bi
- Page 66 and 67:
Garun garapena lank., 1984; Gayo et
- Page 68 and 69:
Organo periferikoen garapena 6.ORGA
- Page 70 and 71:
Organo periferikoen garapena Peptid
- Page 72 and 73:
Organo periferikoen garapena eta la
- Page 74 and 75:
Organo periferikoen garapena Birike
- Page 76:
Organo periferikoen garapena ondore
- Page 79 and 80:
Zahartzapena Entzefalinak eta TRH-a
- Page 81 and 82:
Zahartzapena Bradikininaren hartzai
- Page 83 and 84:
Zahartzapena igoerarekin bat dator.
- Page 86 and 87:
HELBURUA
- Page 88 and 89:
HELBURUA Helburua Organismoaren haz
- Page 90 and 91:
Helburua Peptidasa solugarrien egin
- Page 92 and 93:
MATERIALAK ETA METODOAK
- Page 94 and 95:
MATERIALAK ETA METODOAK Materialak
- Page 96 and 97:
3. PRODUKTU KIMIKOAK o Azetato sodi
- Page 98 and 99:
Materialak 4.2.ENTSEIU ENTZIMATIKOE
- Page 100 and 101:
B. METODOAK 1. ANIMALIEN PERFUSIO E
- Page 102 and 103:
1. IRUDIA: Animaliaren perfusioa. M
- Page 104 and 105:
3. IRUDIA: Garunaren lehenengo ebak
- Page 106 and 107:
2. LAGINEN PRESTAKUNTZA Metodoak Au
- Page 108 and 109:
Metodoak 3.AKTIBITATE ENTZIMATIKOAR
- Page 110 and 111:
Teknika Metodoak Substratu soluzioa
- Page 112 and 113:
Metodoak Materialak eta Metodoak 95
- Page 114 and 115:
EMAITZAK Prolil endopeptidasa solug
- Page 116:
UP/mg proteina 3000 2000 1000 0 Pro
- Page 119 and 120:
Mintzari loturiko prolil endopeptid
- Page 122 and 123:
1.2. PIROGLUTAMIL PEPTIDASA I 1.2.1
- Page 124:
UP/mg proteina 5000 4000 3000 2000
- Page 127 and 128:
Mintzari loturiko piroglutamil pept
- Page 129 and 130:
Prolil endopeptidasa garapenean 112
- Page 131 and 132:
Prolil endopeptidasa garapenean ham
- Page 133 and 134:
Prolil endopeptidasa garapenean PRO
- Page 135 and 136:
Prolil endopeptidasa garapenean Kor
- Page 137 and 138:
Prolil endopeptidasa solugarria gar
- Page 139 and 140:
Prolil endopeptidasa solugarria gar
- Page 141 and 142:
Prolil endopeptidasa solugarria gar
- Page 143 and 144:
Mintzari loturiko prolil endopeptid
- Page 146 and 147:
Mintzari loturiko prolil endopeptid
- Page 148 and 149:
Mintzari loturiko prolil endopeptid
- Page 150 and 151:
Mintzari loturiko prolil endopeptid
- Page 152 and 153:
UP/mg proteina 3000 2000 1000 0 Min
- Page 154 and 155:
UP/mg proteina 500 400 300 200 100
- Page 156 and 157:
UP/mg proteina 300 200 100 0 Mintza
- Page 158 and 159:
Piroglutamil peptidasa I solugarria
- Page 160 and 161:
Piroglutamil peptidasa I solugarria
- Page 162 and 163:
Piroglutamil peptidasa I solugarria
- Page 164 and 165:
Piroglutamil peptidasa I solugarria
- Page 166 and 167:
Piroglutamil peptidasa I solugarria
- Page 168 and 169:
Piroglutamil peptidasa I solugarria
- Page 170 and 171:
Mintzari loturiko piroglutamil pept
- Page 172 and 173:
Mintzari loturiko piroglutamil pept
- Page 174 and 175:
UP/mg proteina 600 400 200 0 Mintza
- Page 176 and 177:
UP/mg proteina 400 300 200 100 0 Mi
- Page 178 and 179:
UP/mg proteina 400 300 200 100 0 Mi
- Page 180 and 181:
UP/mg proteina 200 150 100 50 0 Min
- Page 182 and 183:
UP/mg proteina 150 100 50 0 Mintzar
- Page 184 and 185:
Prolil endopeptidasa zahartzapenean
- Page 186 and 187:
Prolil endopeptidasa zahartzapenean
- Page 188 and 189:
Prolil endopeptidasa zahartzapenean
- Page 190 and 191:
Prolil endopeptidasa zahartzapenean
- Page 192 and 193:
Prolil endopeptidasa zahartzapenean
- Page 194 and 195:
Piroglutamil peptidasa I solugarria
- Page 196 and 197:
UP/ mg proteina 400 300 200 100 0 P
- Page 198:
UP/ mg proteina 5000 4000 3000 2000
- Page 201 and 202:
Piroglutamil peptidasa I solugarria
- Page 203 and 204:
Piroglutamil peptidasa I solugarria
- Page 205 and 206:
EZTABAIDA
- Page 207 and 208: EZTABAIDA 1. PROLIL ENDOPEPTIDASA P
- Page 209 and 210: Prolil endopeptidasa Jaio berrian e
- Page 211 and 212: Prolil endopeptidasa peptido hauek
- Page 213: Prolil endopeptidasa 1.4. PROLIL EN
- Page 216 and 217: Piroglutamil peptidasa I Lehen aipa
- Page 218 and 219: Piroglutamil peptidasa I TRH-aren e
- Page 221 and 222: Emaitzen Analisi orokorra 3. EMAITZ
- Page 223 and 224: ONDORIOAK
- Page 225 and 226: ONDORIOAK Ondorioak 1. Prolil endop
- Page 228: BIBLIOGRAFIA
- Page 231 and 232: Bibliografia Aoyagi, T., Hatsu, M.,
- Page 233 and 234: Bibliografia Berl, S. and Clarke, D
- Page 235 and 236: Bibliografia Carr, F. E., Need, L.
- Page 237 and 238: Bibliografia de Gandarias, J. M., C
- Page 239 and 240: Bibliografia el-Dahr, S. S., 1997.
- Page 241 and 242: Bibliografia Gil, J., 1997. Ontogen
- Page 243 and 244: Bibliografia importance of cardiac
- Page 245 and 246: Bibliografia converting enzyme inhi
- Page 247 and 248: Bibliografia Lee, H. J., Sagawa, K.
- Page 249 and 250: Bibliografia Manaker, S., Eichen, A
- Page 251 and 252: Bibliografia hormone (TRH) in the p
- Page 253 and 254: Bibliografia Otto, C., Zuschratter,
- Page 255 and 256: Bibliografia Re, R. N., 2003a. Impl
- Page 257: Bibliografia Sidman, R. L., 1961. H
- Page 261 and 262: Bibliografia Weil-Malherbe, H., 197
- Page 263: Bibliografia Zagon, I. S., Verderam